HHS Deal To Speed Domestic MPX Vaccine Production

August 29, 2022 Biden Administration, Monkeypox

Axios reports:

The Biden administration struck an $11 million deal on Monday to support the packaging of the monkeypox Jynneos vaccine at a domestic facility. The move is another step the administration is taking to bolster the supplies of the vaccine amid limited availability.

The Jynneos vaccine is produced by the Danish company Bavarian Nordic, which signed a deal earlier this month with Michigan-based company Grand River Aseptic Manufacturing (GRAM) “to establish the first fill and finish line” for vials of the vaccine in the U.S.

“We continue to build on our efforts to secure and make safe and effective vaccines readily available,” HHS Secretary Xavier Becerra said in the press release. “This new agreement solidifies a domestic manufacturing capability that will bring us more vaccine sooner to end this outbreak,” he added.

Yahoo News reports:



The monkeypox outbreak is showing early signs of waning, with some areas of the country — and world — reporting fewer cases on average. CDC Director Dr. Rochelle Walensky told Yahoo Finance Friday that the agency has noted the decline in some regions.

But while some urban jurisdictions show signs of slowing — like New York, Chicago, and San Francisco — others are still seeing a rise. However, the signs have given Walensky a reason to be cautiously optimistic, she said Friday.

Walensky credited the “harm reduction messages being heard and implemented.” A new report from the CDC showed 50% of MSM have altered their behavior in order to avoid being infected.

Tags

© joemygod.com 2025